OTC: VYND
Vynleads, Inc.CIK 0001745078 · SIC 7200 · Personal Services
Unless the context indicates or suggests otherwise, references to 'we,' 'our,' 'us,' the 'Company,' or 'Vynleads' refer to Vynleads, Inc., a Delaware corporation. About this business →
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (CNXC 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade VYND commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Nov 16, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Statements of Operations (Unaudited)
| Description | Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 |
|---|---|---|---|---|
| Revenue, net of refunds and chargebacks | — | — | — | — |
| Cost and Expenses | ||||
| Cost of revenue | 2,281 | (3,972) | 7,295 | 4,471 |
| Gross Loss | (2,281) | 3,972 | (7,295) | (4,471) |
| Operating Expenses | ||||
| Selling, general and administrative expenses | 59,679 | 60,584 | 211,104 | 188,303 |
| Total Operating Expenses | 59,679 | 60,584 | 211,104 | 188,303 |
| Loss from operations | (61,960) | (56,612) | (218,399) | (192,774) |
| Other Income (Expenses) from operations | ||||
| Gain on debt settlement | — | — | — | — |
| Interest expense | (2,863) | (1,457) | (7,269) | (3,346) |
| Total Other Income (Expenses), net | (2,863) | (1,457) | (7,269) | (3,346) |
| Net loss before provision for income taxes | (64,823) | (58,069) | (225,668) | (196,120) |
| Income Taxes | — | — | — | — |
| NET LOSS | (64,823) | (58,069) | (225,668) | (196,120) |
| NET LOSS PER COMMON SHARE: BASIC AND DILUTED | (0.00) | (0.00) | (0.01) | (0.01) |
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED | 18,327,364 | 18,327,364 | 18,327,364 | 18,327,364 |
Balance Sheets
| Description | September 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current Assets: | ||
| Cash | 43,904 | 44,628 |
| Prepaid expenses and other current assets | 4,581 | 9,081 |
| Total current assets | 48,485 | 53,709 |
| Total assets | 48,485 | 53,709 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
| Current Liabilities: | ||
| Accounts payable and accrued expenses | 248,722 | 240,818 |
| Notes payable | 280,362 | 165,322 |
| Total current liabilities | 529,084 | 406,140 |
| Total liabilities | 529,084 | 406,140 |
| Commitments and contingencies (See Note 6) | — | — |
| Stockholders' Deficit: | ||
| Preferred stock; $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding, respectively | — | — |
| Common stock; $0.0001 par value; 50,000,000 shares authorized; 18,327,364 and 18,327,364 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | 1,833 | 1,833 |
| Additional paid-in capital | 2,783,832 | 2,686,332 |
| Accumulated deficit | (3,266,264) | (3,040,596) |
| Total stockholders' deficit | (480,599) | (352,431) |
| Total liabilities and stockholders' deficit | 48,485 | 53,709 |
Statements of Cash Flows (Unaudited)
| Description | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | (225,668) | (196,120) |
| Adjustments to reconcile net loss to net cash flows used in operating activities: | ||
| In kind contribution of services | 97,500 | 97,500 |
| Decrease in prepaid expenses and other current assets | 4,500 | 13,784 |
| Increase in accounts payable and accrued expenses | 7,944 | 2,670 |
| Net cash flows used in operating activities | (115,724) | (82,166) |
| Cash flows from financing activities: | ||
| Repayment of PPP Loan | — | (500) |
| Proceeds from notes payable | 115,000 | 50,000 |
| Net cash flows provided by (used in) financing activities | 115,000 | 49,500 |
| Net decrease in cash | (724) | (32,666) |
| Cash at beginning of period | 44,628 | 68,988 |
| Cash at end of period | 43,904 | 36,322 |
| Supplemental disclosure of cash flow information: | ||
| Income taxes paid | — | — |
| Interest paid | — | — |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗
About Vynleads, Inc.
Source: Item 1 (Business) from the 10-K filed March 31, 2026. Description as filed by the company with the SEC.
ITEM 1. BUSINESS
Unless the context indicates or suggests otherwise,
references to 'we,' 'our,' 'us,' the 'Company,' or 'Vynleads' refer to Vynleads, Inc., a Delaware corporation.
FORWARD-LOOKING STATEMENTS
This annual report contains forward-looking statements.
These statements relate to future events, anticipated platform capabilities, prospective enterprise relationships, our product roadmap,
our market positioning and our future financial performance. These statements often can be identified by the use of terms such as 'may,'
'will,' 'expect,' 'believe,' 'anticipate,' 'estimate,' 'intend,' 'plan,' 'project' or similar expressions. We intend that such forward-looking
statements be subject to the safe harbors for such statements. We caution readers not to place undue reliance on any forward-looking statements,
which speak only as of the date made. Any forward-looking statement represents management's best judgment as to what may occur in the
future, but forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual
results and events to differ materially from those presently anticipated or projected. We disclaim any obligation to update any forward-looking
statements after the date of this report, whether as a result of new information, future events or otherwise.
GENERAL
History of our company
Our corporation was formed in Delaware in July
2015. We introduced the Done With Diabetes brand in 2016 as a lifestyle-first wellness offering for individuals seeking clearer structure
and support around metabolic health habits. Since launch, the Company has evolved from marketing discrete digital wellness information
products and related offerings toward a technology-enabled platform model centered on recurring engagement, personalization and ongoing
support.
Read full description ↓
During 2026, we began repositioning our go-to-market
around an app-based subscription offering. In January 2026, we introduced the broader Done With, or DWX, platform vision, which management
believes may serve as a repeatable technology and content framework for additional lifestyle-first condition programs over time. This
repositioning reflects a shift toward recurring digital engagement, AI-enabled coaching, community-driven support and a more scalable
platform architecture, including agentic AI workflows in which specialized software agents may collaborate with one another and with users
across the member journey.
Our mission is to provide lifestyle-first, educational
wellness support that helps people build sustainable routines around nutrition, movement, self-monitoring and accountability. We are not
a medical provider and our consumer-facing offerings are intended for general wellness and educational purposes only.
Additional information about Vynleads is available
at www.vynleads.com.
Overview
Vynleads is a wellness technology company focused
on metabolic health and chronic, lifestyle-influenced conditions. Our flagship offering is Done With Diabetes, an eight-week structured
program delivered through our digital platform and supported by our proprietary Lifestyle Blueprint personalization engine, Dr. Smith
AI Coach and an emerging agentic AI support architecture. Our strategic objective is to combine evidence-informed content, behavior change
design, community accountability and AI-enabled support in a format that can be delivered directly to consumers and, over time, through
enterprise partners such as self-insured employers, health plans, payers, provider groups and pharmacy benefit managers. Management believes
that, if successfully implemented, specialized AI agents that can interact with members and coordinate with one another may improve responsiveness,
continuity and scalability across the platform.
Our current positioning reflects a shift from
a one-time content model to a recurring platform model. We are designing the product for daily use rather than occasional reference, with
a fixed 56-day journey, progressive phases, daily missions and a maintenance layer intended to continue beyond the initial program. Management
believes the same underlying technology, content and workflow architecture, including AI-enabled and potentially agentic support layers,
may support additional condition-specific programs under our broader DWX platform vision and may allow a higher degree of personalization
and scalability than a purely static content model, although there can be no assurance when or whether such programs or benefits will
be realized.
1
The Done With Diabetes platform
Done With Diabetes is an app-based, lifestyle-first
wellness support program for adults with type 2 diabetes, prediabetes and related metabolic health goals. The current consumer product
is offered on a subscription basis and is built around a 56-day Success Blueprint that guides users through four sequential phases: Foundation,
Meal Plan, Lifestyle and Control. The program is designed to combine practical education, habit formation and accountability in a structured
user journey and to use AI-enabled workflows to help determine what content, prompts and support experiences are most relevant at each
stage.
After account creation, users complete an onboarding
flow that captures lifestyle profile information, goals, areas of focus and other baseline inputs. Based on those inputs and ongoing engagement,
the platform assigns a personalized Success Blueprint and surfaces daily missions, educational content, meal guidance, recipe recommendations,
check-ins, progress dashboards and coaching prompts intended to help users stay consistent. For logged-in users, chat sessions and activity
history are intended to persist across sessions so that the coaching layer can respond in the context of the user's program progress.
The AI support layer is designed to retrieve condition-specific program knowledge, current lesson content, recipes, exercises, motivational
messages and other contextual content associated with the user's current week, day, streak and recent activity.
The current product experience includes Dr. Smith
AI Coach, personalized meal guidance, a diabetes-friendly recipe library with more than 43 recipes, daily activity and wellness tasks,
progress dashboards, metric tracking, community features and gamified engagement tools such as points, streaks, leaderboards, a Daily
Spin and a Wellness Garden. We are also building a broader agentic architecture in which specialized AI agents may perform or coordinate
discrete functions such as conversational coaching, knowledge retrieval, pattern recognition, recommendation generation, engagement prompting
and selected community-support workflows. In certain cases, structured context may be passed among these agents so that user-facing interactions
remain coherent across sessions and across different surfaces of the platform, including experiences involving both AI systems and human
community members. After the initial 56-day program, users transition into Lifetime Wellness Mode, which is intended to support maintenance,
relapse prevention and longer-term consistency through ongoing recommendations, missions, recipes and challenges.
Although our platform addresses blood sugar, energy,
weight-management and related lifestyle goals, our consumer-facing offering is positioned as educational information and wellness support,
not diagnosis, treatment or medical care. Users are advised to consult qualified healthcare professionals regarding medical conditions
and before making medication, diet or exercise changes.
Revenue model and monetization
Our current product strategy emphasizes recurring
digital revenue. As of the date of this report, the Done With Diabetes app is marketed with a seven-day free trial followed by a $29 per
month subscription. Management believes this pricing model may support broad accessibility while also aligning our economics with longer-term
user engagement, retention and lifetime value. Management also believes that, if successfully deployed, AI-enabled and agentic support
workflows may improve the platform's ability to personalize member experiences without requiring a strictly one-to-one increase in human
support resources.
Historically, the Company also generated revenue
from discrete digital wellness products, newsletters and nutritional supplements. While management may continue to evaluate complementary
wellness offerings and adjacent monetization channels, our principal strategic focus is now on scaling the app-based subscription platform,
strengthening the AI and agentic product layer and building a broader, repeatable technology foundation.
In addition to direct-to-consumer subscriptions,
we intend to pursue enterprise distribution and sponsored deployment opportunities. Depending on structure, enterprise revenue may in
future include per-participant fees, contractual program access fees, implementation fees, reporting services or other recurring arrangements.
Management believes that our combination of structured content, community workflows and AI-enabled, potentially agentic support may be
relevant to organizations seeking scalable lifestyle programs without a fully labor-intensive coaching model. There can be no assurance
as to the timing or scale of such enterprise relationships.
Market opportunity and customer segments
We currently focus on adults with type 2 diabetes,
prediabetes and broader metabolic health challenges who are seeking structured, non-judgmental, lifestyle-first support. We also believe
there is a commercial opportunity to make our platform available through institutional stakeholders seeking scalable engagement tools
for the populations they serve, including employers, health plans, payers, provider organizations and pharmacy benefit managers.
Beyond metabolic health, management believes the
platform architecture may be extensible to additional chronic or habit-influenced conditions. As part of our DWX platform vision, we have
publicly discussed possible future programs addressing heart disease and depression. Any expansion beyond our initial flagship program
will depend on product development, regulatory considerations, market demand, capital availability and management priorities. See Figure
1 below for an illustration of this platform framework.
2
Figure 1. Illustrative DWX platform architecture,
showing the launched Done With Diabetes program and selected illustrative future program areas.
Marketing and sales
Our consumer go-to-market model is digitally native.
We use a mix of branded website traffic, educational content, search visibility, press coverage, social media, referrals, community engagement
and performance marketing to attract prospective users to the Vynleads ecosystem and into our app onboarding flow. We believe the combination
of educational content and product-led conversion is important because users evaluating metabolic health support often want both practical
guidance and a trusted entry point before subscribing.
Our website serves several complementary roles.
It introduces the Company's positioning, describes the Done With Diabetes protocol, explains our technology, supports investor and enterprise
messaging, and hosts an educational content hub intended to increase organic reach and trust. Users who choose to enroll are directed
into the app environment, where account creation, onboarding, subscription selection and program engagement occur.
Our enterprise strategy is relationship-driven
and may involve longer sales cycles than direct-to-consumer acquisition. Prospective enterprise customers may evaluate us based on program
quality, participant engagement, information security, reporting capabilities, cost-effectiveness, clinical alignment, compliance posture
and implementation requirements. As a result, enterprise adoption may require product enhancements, administrative tooling and reporting
workflows beyond the core consumer experience.
Competition
We operate in competitive and rapidly evolving
markets. On the consumer side, we compete with digital health and wellness applications, nutrition and habit-tracking products, diabetes
education services, weight-management platforms, coaching programs, general health content publishers and free online resources. On the
enterprise side, we compete with broader wellness vendors, digital condition-management platforms, point solutions focused on metabolic
health, and organizations that build internal support programs.
We believe the principal bases of competition
in our market are product clarity, personalization, agentic AI orchestration, continuity of support, user engagement, retention, brand
trust, content quality, ease of use, affordability, outcomes storytelling, data privacy, enterprise readiness and the ability to serve
users consistently between formal healthcare encounters. Many current and potential competitors have substantially greater financial,
technical, marketing and organizational resources than we do.
3
Information systems
Our business depends on a cloud-based digital
platform and a combination of internally developed workflows and third-party technology services. Our platform architecture is designed
to manage user accounts, profile and onboarding data, program enrollment, daily missions, recipes and meal guidance, community participation,
AI chat sessions, progress tracking, subscriptions, administrative reporting and, over time, a broader orchestration layer for AI-enabled
and agentic support.
The user experience is organized around a structured
data model that links each enrolled member to a personalized profile, a program phase, daily tasks and relevant engagement records such
as metric entries, streaks, points, AI chat sessions and community activity. We believe this architecture supports consistent delivery
of daily content, personalized prompts, habit reinforcement and future reporting capabilities for enterprise deployments, including organization-level
provisioning and reporting. We also believe it provides the context needed for AI systems and specialized agents to remain aware of where
a user is in the program and what support may be most relevant next.
Our AI-enabled features, including Dr. Smith AI
Coach and other automated engagement functions, rely on a combination of program content, onboarding inputs, user activity signals and
model-driven response logic. We are also designing the platform to support specialized AI agents that may retrieve program knowledge,
generate context-aware guidance, identify patterns in user behavior, surface recipes or daily missions, and support selected community
and accountability workflows. In some cases, these agents may communicate with one another or pass structured context across workflows
before interacting with the user. Management believes this architecture may improve responsiveness, personalization and scalability, but
it also increases operational complexity and reliance on controls over data access, model behavior, tool use and third-party infrastructure.
See Figure 2 below for an illustration of this agentic support architecture.
Figure 2. Illustrative agentic support architecture,
showing Dr. Smith AI Coach, specialized AI-agent coordination and AI-to-human support pathways.
Intellectual property
We rely on a combination of trademarks, copyrights,
trade secrets, contractual restrictions, domain names, platform know-how and other proprietary rights to protect our business. Our brand
portfolio includes Vynleads, Done With Diabetes, Lifestyle Blueprint and Dr. Smith AI Coach, together with related content libraries,
workflows, educational materials, user experience design and software logic.
Our continued success depends in part on our ability
to maintain our brand reputation, protect the confidentiality of proprietary content and product designs, and operate without infringing
the rights of others. We may not be able to prevent third parties from copying aspects of our brand, content or platform structure, particularly
in online markets where content can be republished or imitated quickly.
4
Government regulation
Our operations are subject to a variety of laws
and regulations at the federal, state and local levels. These may include laws relating to consumer protection, advertising and marketing,
automatic renewal and subscription practices, privacy and data security, electronic communications, intellectual property, payment processing,
artificial intelligence, unfair or deceptive acts or practices, and online commerce.
Because our products address wellness topics that
are closely related to medical conditions, we must also consider how our claims, disclosures, content presentation and user experience
may be interpreted by consumers, regulators, advertising platforms, distribution partners and enterprise counterparties. Our public materials
emphasize that our consumer-facing offerings provide educational information and wellness support only and are not intended to diagnose,
treat, cure or prevent disease. If regulators or counterparties disagree with our positioning or with the manner in which our content
or features are presented, we could face scrutiny, claims or restrictions.
As we pursue enterprise partnerships and broader
platform capabilities, we may become subject to additional contractual, industry or regulatory expectations relating to privacy, cybersecurity,
reporting, accessibility and the handling of health-related information. We may also need to adapt our processes as laws governing AI-enabled
systems and digital wellness tools continue to evolve.
Employees
At March 24, 2026, we had one employee, including
our chief executive officer. Given our current scale, we rely significantly on third-party service providers, consultants and technology
partners for selected operational, development and support functions.